New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins

Tn antigen ( -O-GalNAc-Ser/Thr) is one of the most specific human tumorassociated structures. This motif is implicated in HIV infection and it is expressed early in tumor cells. It has been observed that there is a direct correlation between carcinoma aggressiveness and the density of this antigen....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Madariaga Merino, David
Otros Autores: Peregrina García, Jesús Manuel (Universidad de La Rioja)
Formato: text (thesis)
Lenguaje:eng
Publicado: Universidad de La Rioja (España) 2015
Acceso en línea:https://dialnet.unirioja.es/servlet/oaites?codigo=44390
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai-TES0000007535
record_format dspace
institution DialNet
collection DialNet
language eng
description Tn antigen ( -O-GalNAc-Ser/Thr) is one of the most specific human tumorassociated structures. This motif is implicated in HIV infection and it is expressed early in tumor cells. It has been observed that there is a direct correlation between carcinoma aggressiveness and the density of this antigen. For this reason, Tn determinant is a convenient cancer biomarker. Mucin-like glycopeptides and glycoproteins, in particular MUC1, incorporate this structure in their sequence. While in normal cells this O-glycosylated protein carries complex oligosaccharides, in cancer cells, MUC1 expression is increased and its glycans are short and poorly branched. Therefore, Tn antigen is now exposed to the immune system generating an immunological response. From a structural point of view, Tn antigen is referred to Nacetylgalactosamine (GalNAc) -O-linked to serine (Ser) or threonine (Thr), not discriminating the amino acid to which GalNAc is linked. However, in this Thesis, we have synthesized different representative MUC1 epitopes bearing Ser and Thr in their structure and we have detected differences between these two amino acids in terms of affinity to lectins. As a result, it is important to mention specifically the underlying amino acid in Tn antigen. We have also analyzed the role of flanking amino acids of Tn antigen in the peptide chain, getting surprising results in terms of affinity to lectins. In addition, we have obtained an X-ray structure by the first time of soybean agglutinin (SBA) lectin linked to a MUC1-derived glycopeptide. All these results may have important implications for better understanding the glycopeptide-lectin interactions and may contribute to engineer new binding sites, allowing the design of novel glycosensors for Tn antigen detection in tumor cells.
author2 Peregrina García, Jesús Manuel (Universidad de La Rioja)
author_facet Peregrina García, Jesús Manuel (Universidad de La Rioja)
Madariaga Merino, David
format text (thesis)
author Madariaga Merino, David
spellingShingle Madariaga Merino, David
New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
author_sort Madariaga Merino, David
title New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
title_short New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
title_full New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
title_fullStr New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
title_full_unstemmed New insights into molecular recognition of epitopes related to MUC1 human mucin by lectins
title_sort new insights into molecular recognition of epitopes related to muc1 human mucin by lectins
publisher Universidad de La Rioja (España)
publishDate 2015
url https://dialnet.unirioja.es/servlet/oaites?codigo=44390
work_keys_str_mv AT madariagamerinodavid newinsightsintomolecularrecognitionofepitopesrelatedtomuc1humanmucinbylectins
_version_ 1718346624014483456
spelling oai-TES00000075352019-07-06New insights into molecular recognition of epitopes related to MUC1 human mucin by lectinsMadariaga Merino, DavidTn antigen ( -O-GalNAc-Ser/Thr) is one of the most specific human tumorassociated structures. This motif is implicated in HIV infection and it is expressed early in tumor cells. It has been observed that there is a direct correlation between carcinoma aggressiveness and the density of this antigen. For this reason, Tn determinant is a convenient cancer biomarker. Mucin-like glycopeptides and glycoproteins, in particular MUC1, incorporate this structure in their sequence. While in normal cells this O-glycosylated protein carries complex oligosaccharides, in cancer cells, MUC1 expression is increased and its glycans are short and poorly branched. Therefore, Tn antigen is now exposed to the immune system generating an immunological response. From a structural point of view, Tn antigen is referred to Nacetylgalactosamine (GalNAc) -O-linked to serine (Ser) or threonine (Thr), not discriminating the amino acid to which GalNAc is linked. However, in this Thesis, we have synthesized different representative MUC1 epitopes bearing Ser and Thr in their structure and we have detected differences between these two amino acids in terms of affinity to lectins. As a result, it is important to mention specifically the underlying amino acid in Tn antigen. We have also analyzed the role of flanking amino acids of Tn antigen in the peptide chain, getting surprising results in terms of affinity to lectins. In addition, we have obtained an X-ray structure by the first time of soybean agglutinin (SBA) lectin linked to a MUC1-derived glycopeptide. All these results may have important implications for better understanding the glycopeptide-lectin interactions and may contribute to engineer new binding sites, allowing the design of novel glycosensors for Tn antigen detection in tumor cells.El antígeno Tn ( -O-GalNAc-Ser/Thr) es una de las estructuras asociadas a tumores más específicas en humanos. Esta molécula está implicada en la infección del VIH y en su expresión temprana en células tumorales. También se ha observado una relación directa entre la agresividad de un carcinoma y la concentración de dicho antígeno. Por ello, el antígeno Tn está considerado como un importante biomarcador del cáncer. Los glicopéptidos y glicoproteínas tipo mucina, en particular la mucina humana MUC1, incorporan en su estructura el antígeno Tn. Mientras que en las células sanas esta O-glicoproteína de membrana tiene oligosacáridos complejos, en células cancerosas, la expresión de MUC1 aumenta y sus glicanos son cortos y poco ramificados. Esto hace que el antígeno Tn quede expuesto al sistema inmune generando una respuesta inmunológica. Desde el punto de vista estructural, el antígeno Tn está formado por Nacetilgalactosamina (GalNAc) unida mediante un enlace -O-gliosídico a serina (Ser) o treonina (Thr), sin especificar a qué aminoácido se une el GalNAc. Sin embargo, en esta tesis hemos sintetizado diferentes epítopos representativos de MUC1 que incorporan Ser y Thr en su estructura. Hemos analizado las interacciones que ocurren en el reconocimiento de GalNAc por diferentes lectinas, observando que es importante especificar a qué aminoácido se une el residuo carbohidrato GalNAc. También hemos analizado la importancia de los aminoácidos que rodean al antígeno Tn en la cadena peptídica, obteniendo resultados sorprendentes en términos de afinidad a lectinas. Además, hemos obtenido por primera vez, una estructura de rayos X de la lectina soybean agglutinin (SBA) unida a un glycopéptido derivado de la mucina humana MUC1. Todos estos resultados podrían tener importantes implicaciones para entender mejor las interacciones glicopéptido-lectina y podría contribuir al diseño y construción de nuevos sitios de unión, permitiendo el diseño de nuevos glicosensores para la detección de antígeno Tn en células tumoralesUniversidad de La Rioja (España)Peregrina García, Jesús Manuel (Universidad de La Rioja)Corzana López, Francisco (Universidad de La Rioja)2015text (thesis)application/pdfhttps://dialnet.unirioja.es/servlet/oaites?codigo=44390engLICENCIA DE USO: Los documentos a texto completo incluidos en Dialnet son de acceso libre y propiedad de sus autores y/o editores. Por tanto, cualquier acto de reproducción, distribución, comunicación pública y/o transformación total o parcial requiere el consentimiento expreso y escrito de aquéllos. Cualquier enlace al texto completo de estos documentos deberá hacerse a través de la URL oficial de éstos en Dialnet. Más información: https://dialnet.unirioja.es/info/derechosOAI | INTELLECTUAL PROPERTY RIGHTS STATEMENT: Full text documents hosted by Dialnet are protected by copyright and/or related rights. This digital object is accessible without charge, but its use is subject to the licensing conditions set by its authors or editors. Unless expressly stated otherwise in the licensing conditions, you are free to linking, browsing, printing and making a copy for your own personal purposes. All other acts of reproduction and communication to the public are subject to the licensing conditions expressed by editors and authors and require consent from them. Any link to this document should be made using its official URL in Dialnet. More info: https://dialnet.unirioja.es/info/derechosOAI